Biocon Ltd. — Regulatory Filings 2026

Jun 8, 2026

Biocon

Biocon Limited
20th KM, Hosur Road
Electronic City
Bangalore 560 100, India
T 91 80 2808 2808
F 91 80 2852 3423
CIN : L24234KA1978PLC003417
www.biocon.com

BIO/SECL/TG/2026-27/31
June 08, 2026

To, The Secretary BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001	To, The Secretary National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - BIOCON

Dear Sir/ Madam,

Sub: Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)

Pursuant to Regulation 30(6) of the SEBI Listing Regulations, we wish to inform you that the Management of the Company is participating in the Investor Event as per the details given below:

Date	Event	Type of Interaction	Venue
11-Jun-26	Macquarie's Healthcare Tour – Plant Visit	Group	Bangalore

Note: The above-mentioned schedule is subject to change due to exigencies on the part of Investors/Company.

Kindly note that the Company will not disclose any Unpublished Price Sensitive Information (UPSI) during the analyst(s)/ investor(s) meeting.

The above information will also be available on the website of the Company at www.biocon.com.

We request you to kindly take the above information on record.

Thanking You,

Yours faithfully,

For Biocon Limited

RAJESH
U
SHANOY

Digitally signed
by RAJESH U
SHANOY
Date: 2026.06.08
17:25:55 +05'30'

Rajesh U. Shanoy
Company Secretary and Compliance Officer
Membership No.: ACS 16328